Goldline Pharmaceutical bulk deals and insider trading
BSE: 544759Pharmaceuticals & BiotechnologySmall Cap
Last close ₹30.10up ₹0.12 (0.40%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.98.
Range of traded prices from listing on 19 May 2026 to 23 Oct 2026
₹28.13Low, 21 Oct 2026₹60.00High, 19 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,537th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 9 Jun 2026
- 7.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 9 Jun 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 9 Jun 2026
- 28.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 Jun 2026
- 0.64
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,000
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Goldline Pharmaceutical promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group4 purchases, 0 sales₹0.26 Cr3 mores with no value filedNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.26 Crof the trades with a value
- Directors and key managers1 purchase, 0 salesValue not statedNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.Value not stated
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Goldline Pharmaceutical insider trading
All 5 disclosures on record.Insider trading, all companies
Sep 2026
- Amol Laxmikant Mujumdar18,000sharesBought · Promoter and Director · 1 Sep 2026 · stake 29.27% before, 29.46% after
Aug 2026
- Amol Laxmikant Mujumdar60,000sharesBought · Promoter and Director · 31 Aug 2026 · stake 28.64% before, 29.27% after
- Swapan Khandelwal78,000sharesBought · Promoter and Director · 28 Aug 2026 · disclosed 29 Aug · stake 29.27% before, 30.08% after
Jul 2026
- Prashant Shrikrishna Karkare27,000sharesBought · Director · 28 Jul 2026 · held 3 before, holds 27,003 after, stake 0.28% after
Jun 2026
- Swapan Khandelwal₹0.26 Cr60,000 sharesBought · Promoter and Director · 22 Jun 2026 · disclosed 23 Jun · stake 28.65% before, 29.27% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Goldline Pharmaceutical bulk deals
Last 12 months, since 23 Oct 2025: 54 bulk deals, ₹11 Cr bought and ₹11 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 1 Sep 20261 firm · ₹0.21 Cr bought · ₹0.21 Cr soldNet nil
- Both waysPRIYA KABRABought 51,000 at ₹40.91Sold 51,000 at ₹40.710.53% of the companyNet nil₹0.21 Cr bought
Monday 31 Aug 20262 firms · ₹0.25 Cr bought · ₹0.25 Cr soldNet nil
- BoughtAMOL LAXMIKANT MUJUMDARBought 60,000 at ₹41.000.63% of the company₹0.25 Cr
- SoldVEER SINGH THAKURSold 60,000 at ₹41.000.63% of the company₹0.25 Cr
Friday 28 Aug 20261 firm · ₹0.32 Cr bought · ₹0 soldNet bought ₹0.32 Cr
- BoughtSWAPAN KHANDELWALBought 78,000 at ₹40.970.81% of the company₹0.32 Cr
Tuesday 25 Aug 20264 firms · ₹0.83 Cr bought · ₹0.60 Cr soldNet bought ₹0.23 Cr
- BoughtAJIT SINGHBought 60,000 at ₹40.040.63% of the company₹0.24 Cr
- SoldCUMULATIVE CAPITAL PRIVATE LIMITEDSold 51,000 at ₹40.150.53% of the company₹0.20 Cr
- Both waysVEER SINGH THAKURBought 51,000 at ₹40.15Sold 3,000 at ₹40.000.53% of the companyNet +48,000 shares₹0.20 Cr bought
- Both waysKAILASH KABRABought 96,000 at ₹40.14Sold 96,000 at ₹40.101.00% of the companyNet nil₹0.39 Cr bought
Monday 24 Aug 20262 firms · ₹0.20 Cr bought · ₹0.20 Cr soldNet nil
- BoughtCUMULATIVE CAPITAL PRIVATE LIMITEDBought 51,000 at ₹38.900.53% of the company₹0.20 Cr
- SoldUPSURGE OPPORTUNITIES FUND 1Sold 51,000 at ₹38.900.53% of the company₹0.20 Cr
Friday 21 Aug 20263 firms · ₹0.50 Cr bought · ₹0.71 Cr soldNet sold ₹0.21 Cr
- SoldUPSURGE OPPORTUNITIES FUND 1Sold 51,000 at ₹41.050.53% of the company₹0.21 Cr
- Both waysSAMURAI SECURITIES PVT LTDBought 51,000 at ₹41.05Sold 51,000 at ₹40.890.53% of the companyNet nil₹0.21 Cr bought
- Both waysKAILASH KABRABought 72,000 at ₹41.01Sold 72,000 at ₹41.030.75% of the companyNet nil₹0.30 Cr bought
Thursday 20 Aug 20261 firm · ₹0 bought · ₹0.21 Cr soldNet sold ₹0.21 Cr
- SoldUPSURGE OPPORTUNITIES FUND 1Sold 51,000 at ₹41.200.53% of the company₹0.21 Cr
Wednesday 19 Aug 20264 firms · ₹0.71 Cr bought · ₹0.71 Cr soldNet nil
- BoughtANIL KUMAR RELAN (HUF)Bought 1,20,000 at ₹39.691.25% of the company₹0.48 Cr
- SoldVIKASA INDIA EIF I FUND-SHARE CLASS PSold 1,14,000 at ₹39.671.19% of the company₹0.45 Cr
- SoldVIKASA INDIA EIF I FUND - SHARE CLASS PSold 66,000 at ₹39.790.69% of the company₹0.26 Cr
- BoughtANIL KUMAR RELANBought 60,000 at ₹39.770.63% of the company₹0.24 Cr
Thursday 6 Aug 20262 firms · ₹0.58 Cr bought · ₹0.35 Cr soldNet bought ₹0.23 Cr
- Both waysAVIRAT ENTERPRISEBought 63,000 at ₹41.39Sold 6,000 at ₹41.010.66% of the companyNet +57,000 shares₹0.26 Cr bought
- Both waysPRIYA KABRABought 78,000 at ₹40.69Sold 78,000 at ₹41.240.81% of the companyNet nil₹0.32 Cr bought
Tuesday 28 Jul 20263 firms · ₹0.46 Cr bought · ₹0.98 Cr soldNet sold ₹0.52 Cr
- SoldAMJAY IMPEX PRIVATE LIMITEDSold 1,50,000 at ₹33.381.56% of the company₹0.50 Cr
- Both waysVIRAL TILAK MARUBought 57,000 at ₹33.05Sold 57,000 at ₹37.810.59% of the companyNet nil₹0.19 Cr bought
- Both waysPRIYA KABRABought 72,000 at ₹37.76Sold 72,000 at ₹37.150.75% of the companyNet nil₹0.27 Cr bought
Wednesday 8 Jul 20262 firms · ₹0.63 Cr bought · ₹0.25 Cr soldNet bought ₹0.38 Cr
- BoughtAMJAY IMPEX PRIVATE LIMITEDBought 1,50,000 at ₹42.241.56% of the company₹0.63 Cr
- SoldBHAGWATI RADHESHYAM KHANDELWALSold 60,000 at ₹42.350.63% of the company₹0.25 Cr
Tuesday 23 Jun 20262 firms · ₹0.64 Cr bought · ₹0.53 Cr soldNet bought ₹0.11 Cr
- BoughtBHAGWATI RADHESHYAM KHANDELWALBought 1,35,000 at ₹47.771.41% of the company₹0.64 Cr
- SoldUPSURGE OPPORTUNITIES FUND 1Sold 1,11,000 at ₹47.951.16% of the company₹0.53 Cr
Monday 22 Jun 20262 firms · ₹0.26 Cr bought · ₹0.31 Cr soldNet sold ₹0.05 Cr
- SoldUPSURGE OPPORTUNITIES FUND 1Sold 72,000 at ₹43.080.75% of the company₹0.31 Cr
- BoughtSWAPAN KHANDELWALBought 60,000 at ₹43.050.63% of the company₹0.26 Cr
Thursday 18 Jun 20261 firm · ₹0 bought · ₹0.66 Cr soldNet sold ₹0.66 Cr
- SoldVIKASA INDIA EIF I FUND - SHARE CLASS PSold 1,50,000 at ₹44.001.56% of the company₹0.66 Cr
Wednesday 17 Jun 20261 firm · ₹0 bought · ₹0.22 Cr soldNet sold ₹0.22 Cr
- SoldAVIRAT ENTERPRISESold 51,000 at ₹42.920.53% of the company₹0.22 Cr
Monday 15 Jun 20261 firm · ₹0 bought · ₹0.36 Cr soldNet sold ₹0.36 Cr
- SoldAVIRAT ENTERPRISESold 81,000 at ₹44.720.84% of the company₹0.36 Cr
Wednesday 10 Jun 20261 firm · ₹0.89 Cr bought · ₹0 soldNet bought ₹0.89 Cr
- BoughtAVIRAT ENTERPRISEBought 1,80,000 at ₹49.261.88% of the company₹0.89 Cr
Tuesday 2 Jun 20261 firm · ₹0.05 Cr bought · ₹0.22 Cr soldNet sold ₹0.17 Cr
- Both waysBONANZA PORTFOLIO LIMITEDBought 12,000 at ₹43.82Sold 51,000 at ₹43.730.53% of the companyNet −39,000 shares₹0.05 Cr bought
Monday 1 Jun 20263 firms · ₹0.28 Cr bought · ₹0.90 Cr soldNet sold ₹0.61 Cr
- SoldASHWINI NIRAJ SINGHSold 1,17,000 at ₹50.861.22% of the company₹0.60 Cr
- Both waysNEO APEX SHARE BROKING SERVICES LLPBought 6,000 at ₹46.03Sold 51,000 at ₹50.860.53% of the companyNet −45,000 shares₹0.03 Cr bought
- Both waysBONANZA PORTFOLIO LIMITEDBought 51,000 at ₹50.37Sold 9,000 at ₹46.360.53% of the companyNet +42,000 shares₹0.26 Cr bought
Wednesday 27 May 20263 firms · ₹0.49 Cr bought · ₹0.84 Cr soldNet sold ₹0.34 Cr
- SoldNEO APEX SHARE BROKING SERVICES LLPSold 1,41,000 at ₹43.251.47% of the company₹0.61 Cr
- BoughtASHWINI NIRAJ SINGHBought 1,17,000 at ₹41.921.22% of the company₹0.49 Cr
- SoldSUREKHA SHINDESold 54,000 at ₹41.760.56% of the company₹0.23 Cr
Monday 25 May 20261 firm · ₹0 bought · ₹0.57 Cr soldNet sold ₹0.57 Cr
- SoldNEO APEX SHARE BROKING SERVICES LLPSold 1,23,000 at ₹46.261.28% of the company₹0.57 Cr
Friday 22 May 20262 firms · ₹1.59 Cr bought · ₹1.23 Cr soldNet bought ₹0.36 Cr
- BoughtNEO APEX SHARE BROKING SERVICES LLPBought 3,27,000 at ₹48.693.41% of the company₹1.59 Cr
- SoldCHANDRAPRAKASH KHANDELWALSold 2,52,000 at ₹48.732.63% of the company₹1.23 Cr
Tuesday 19 May 20263 firms · ₹1.88 Cr bought · ₹0.70 Cr soldNet bought ₹1.18 Cr
- BoughtCHANDRAPRAKASH KHANDELWALBought 2,52,000 at ₹59.752.63% of the company₹1.51 Cr
- SoldNIRMAN SHARE BROKERS PVT. LTD.Sold 1,23,000 at ₹57.131.28% of the company₹0.70 Cr
- BoughtSUREKHA SHINDEBought 63,000 at ₹59.750.66% of the company₹0.38 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 54 deals on record since listing on 19 May 2026.